Hap Trading, LLC Arbutus Biopharma Corp Put Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$1.98 - $3.17 $96,030 - $153,745	-48,500 Reduced 70.19%	20,600 $28,000
Q1 2022 May 12, 2022	SELL	$2.42 - $3.98 $86,636 - $142,484	-35,800 Reduced 34.13%	69,100 $46,000
Q4 2021 Feb 14, 2022	BUY	$3.11 - $4.61 $244,757 - $362,807	78,700 Added 300.38%	104,900 $64,000
Q3 2021 Nov 10, 2021	SELL	$2.65 - $4.62 $22,525 - $39,270	-8,500 Reduced 24.5%	26,200 $9,000
Q2 2021 Aug 11, 2021	BUY	$2.5 - $3.51 $32,750 - $45,981	13,100 Added 60.65%	34,700 $7,000
Q4 2020 Feb 16, 2021	BUY	$2.76 - $4.97 $59,615 - $107,352	21,600 New	21,600 $29,000

155

99.5M

2.31M

525K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $478M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.